Related references
Note: Only part of the references are listed.A cost-benefit analysis of the immunisation of children against respiratory syncytial virus (RSV) using the English Hospital Episode Statistics (HES) data set
Gareth Thomas
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2018)
High burden of RSV hospitalization in very young children: a data linkage study
N. Homaira et al.
EPIDEMIOLOGY AND INFECTION (2016)
Lung Function at 8 and 16 Years After Moderate-to-Late Preterm Birth: A Prospective Cohort Study
Per Thunqvist et al.
PEDIATRICS (2016)
Respiratory Syncytial Virus Related Readmission in Preterm Infants Less than 34 weeks' Gestation Following Discharge from a Neonatal Intensive Care Unit in Korea
Jang Hoon Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
Effect of Prophylactic Palivizumab on Admission Due to Respiratory Syncytial Virus Infection in Former Very Low Birth Weight Infants with Bronchopulmonary Dysplasia
Young Mi Han et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
Re: Joan L Robinson, Nicole Le Saux; Canadian Paediatric Society Infectious Diseases and Immunization Committee. Preventing hospitalizations for respiratory syncytial virus infection. Paediatr Child Health 2015; 20(6): 321-333 Response
Joan L. Robinson et al.
PAEDIATRICS & CHILD HEALTH (2015)
Adherence to Palivizumab for Respiratory Syncytial Virus Prevention in the Canadian Registry of Palivizumab
Parco Chan et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)
Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention
Jinghan Jenny Chen et al.
PLOS ONE (2015)
Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program
Brenda B. Poindexter et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)
Lung function of preterm infants before and after viral infections
Simon B. Drysdale et al.
EUROPEAN JOURNAL OF PEDIATRICS (2014)
Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation
D Wang et al.
HEALTH TECHNOLOGY ASSESSMENT (2014)
Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection
Michael T. Brady et al.
PEDIATRICS (2014)
Safety and Effectiveness of Palivizumab in Children at High Risk of Serious Disease Due to Respiratory Syncytial Virus Infection: A Systematic Review
Colleen Wegzyn et al.
INFECTIOUS DISEASES AND THERAPY (2014)
Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective
Nusrat Homaira et al.
INTERNATIONAL JOURNAL OF PEDIATRICS (2014)
Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005-2012) Compared to Other International Registries
Bosco Paes et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Respiratory Syncytial Virus-A Comprehensive Review
Andrea T. Borchers et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2013)
Respiratory Function in Healthy Late Preterm Infants Delivered at 33-36 Weeks of Gestation
Cindy McEvoy et al.
JOURNAL OF PEDIATRICS (2013)
Clinical risk factors are more relevant than respiratory viruses in predicting bronchiolitis severity
Silvia Ricart et al.
PEDIATRIC PULMONOLOGY (2013)
Three monthly doses of palivizumab are not adequate for 5-month protection: A population pharmacokinetic analysis
William V. La Via et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2013)
A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom
Anthony Bentley et al.
HEALTH ECONOMICS REVIEW (2013)
Population Pharmacokinetics of Palivizumab, a Humanized Anti-Respiratory Syncytial Virus Monoclonal Antibody, in Adults and Children
Gabriel J. Robbie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations
B. Paes et al.
EUROPEAN JOURNAL OF PEDIATRICS (2012)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
The risk of mortality among young children hospitalized for severe respiratory syncytial virus infection
Shelagh M. Szabo et al.
Paediatric Respiratory Reviews (2012)
Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses
D. Wang et al.
HEALTH TECHNOLOGY ASSESSMENT (2011)
Outcomes of Palivizumab Prophylaxis for Respiratory Syncytial Virus Infection in Preterm Children with Bronchopulmonary Dysplasia at a Single Hospital in Korea from 2005 to 2009
Seung Gu Chang et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2010)
Prevention of respiratory syncytial virus infection
L. Samson
PAEDIATRICS & CHILD HEALTH (2009)
School age outcome of hospitalisation with respiratory syncytial virus infection of prematurely born infants
A. Greenough et al.
THORAX (2009)
Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry
M. Frogel et al.
JOURNAL OF PERINATOLOGY (2008)
Growth rate of lung function in healthy preterm infants
Luciana Friedrich et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Summary proceedings from the bronchopulmonary dysplasia group
MC Walsh et al.
PEDIATRICS (2006)
Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants
S Broughton et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2006)
Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants
C Pedraz et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2003)
Optimum dosage regimen of palivizumab?
HL Zaaijer et al.
THERAPEUTIC DRUG MONITORING (2002)
Respiratory syncytial virus prophylaxis - the story so far
EAF Simoes et al.
RESPIRATORY MEDICINE (2002)
Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid
TG Boyce et al.
JOURNAL OF PEDIATRICS (2000)
Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation:: a prospective study
X Carbonell-Estrany et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Share Paper
